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ABSTRACT
IS THERE A RELATIONSHIP BETWEEN LIMITED ENGLISH
PROFICIENCY (LEP), MEDICATION ADHERENCE BEHAVIORS, AND
ADVERSE ASTHMA OUTCOMES IN HISPANIC ADULTS WITH
MODERATE TO SEVERE PERSISTENT ASTHMA?

The effects of LEP are well documented in the literature. LEP decreases
medication adherence, causes ineffective communication between patients and providers, and
reduces health outcomes. Asthma is known to be misdiagnosed and under-treated in Hispanic
adults.There are discrepancies in the literature about the effects of LEP in Hispanic adults with
persistent asthma.
The purpose of this study was to determine if the presence of LEP is associated with
medication adherence behaviors and adverse asthma outcomes in Hispanic adults with moderate
to severe persistent asthma. Hispanic adults with LEP were assessed for asthma outcomes and
medication adherence behaviors.
The results of this study revealed that there is no correlation between the level of English
proficiency, asthma outcomes, and medication adherence behaviors in Hispanic adults with LEP.
These findings are a fundamental step towards mitigating the current gaps in the literature. With
the Hispanic population on the rise, further research is needed to develop effective interventions
that will advance the delivery of asthma care and relieve the burdens of asthma management in
Hispanic adults struggling with LEP.
KEY WORDS: Asthma, Persistent asthma, California, Tulare County, Kings County, Hispanic,
Hispanic adult, LEP, health literacy, Moderate to severe persistent asthma.
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CHAPTER 1: INTRODUCTION
Introduction
The considerable adverse effects of language barriers such as limited English proficiency
(LEP), on the quality of health outcomes, have been well documented in the literature (Schwei et
al., 2016). Previous research studies have confirmed that the presence of LEP hinders patients’
access to healthcare services, leads to misconceptions regarding health and self-management
information, affects medication adherence, causes a reduction in the overall quality of care
provided by clinicians, and subsequently, affects patient-provider relationship satisfaction
(Schwei et al., 2016). The Hispanic population, especially, is widely affected by the presence of
LEP. Presently, the Hispanics are believed to be the largest and most rapidly growing minority
group in the United States (US), accounting for 54 million individuals and comprising 17% of
the country’s population (Schembri & Ghaddar, 2017; Sarkar, Asti, Nacion, & Chisolm, 2016).
According to the US Census Bureau, in 2010, approximately 37.5% of the population reported
Spanish as their primary language; 44% of whom were believed to have some level of LEP
(Riera et al., 2015). Spanish-speakers with LEP are more likely to receive suboptimal health
care, experience miscommunication, and be subjected to shorter and less patient-centered office
visits (White, 2015).
Asthma remains one of the most prevalent chronic diseases in the US. It has been well
documented in the literature that the effects of asthma disproportionately influence individuals
belonging to ethnic and racial minority groups (McQuaid, 2018). According to Sofianou et al.
(2012), asthma symptoms are generally misdiagnosed or under-treated in older adult patients.
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Furthermore, the majority of the research and therapy guidelines on asthma thus far have been
essentially directed towards the pediatric population, although earlier studies have confirmed that
morbidity and mortality levels are significantly higher among older adults with asthma (Sofianou
et al., 2012). This has resulted in a conspicuous discrepancy in the data available in the literature
regarding the management of asthma within the adult population. Medication non-adherence, a
prevalent health issue affecting Hispanics with LEP, has been observed across the life-span of
these individuals, and contributes to adverse health outcomes, mainly pertaining to the
management of chronic diseases such as asthma (White, 2015; McQuaid & Landier, 2017). The
current treatment guidelines on asthma have highlighted the regular use of controller medications
as one of the fundamental components associated with improved outcomes in long-term
management of persistent asthma (McQuaid, 2018). Studies performed by the National
Assessment of Adult Literacy (NAAL) and the Pew Research Center have substantiated that
Hispanics have the lowest levels of health literacy when compared to other minority groups in
the US. The decreased level of health literacy in this population is associated with erroneous use
of medications and decreased medication adherence (Sarkar et al., 2016). Research findings have
corroborated that culture may play a crucial role in influencing individual beliefs about
medication usage and adherence. Due to cultural differences, Hispanic patients are more likely to
have opposing beliefs regarding the regular use of controller medications necessary for the
management of persistent asthma (Ahmed & Bates, 2017; McQuaid, 2018).
As the Hispanic population in the US continues to grow, further research is required to
mitigate the gaps that currently exist in the literature regarding the management of chronic
asthma in Hispanic adults with LEP. The findings from these studies will assist healthcare
!2

providers to understand the dynamic needs of this population and lead the way to providing the
high quality and culturally competent care necessary to improve long-term asthma outcomes
within the adult Hispanic population. The intent of this study is to determine if there is a
relationship between LEP, medication adherence behaviors, and asthma outcomes in Hispanic
adults. The study will focus on Hispanic adults aged 18 to 65 years old with moderate to severe
persistent asthma living in the Kings and Tulare counties in California.
Background
LEP is defined as “individuals who do not speak English as their primary language and
who have a limited ability to read, speak, write, or understand English” (Sarkar et al., 2016, p.
609). As reported by the US Census Bureau in 2010, 9% of the population above the age of five
years is affected by varying levels of LEP and the number of people with LEP has increased by
at least 80% between 1990 and 2010 (Schwei et al., 2016). Encounters between providers and
patients who have LEP is fairly common and essentially one in 13 patients in the US is reported
to have LEP. Overall, two-thirds of all hospitals and more than 50% of internists reportedly
interact with a patient who has LEP at least once a week (Andres, Wynia, Regenstein, & Maul,
2013). Previous literature has linked the presence of a language barrier with adverse effects on
health outcomes such as “access to care, health status, use of health services, quality of care,
patient-physician communication, satisfaction with care, and patient safety” (Flores, 2014, p.
1261). According to McQuaid (2018), LEP is also associated with socioeconomic disadvantage.
Spanish-speakers with LEP have been found to receive lower quality care than their
English proficient counterparts, contributing to disparities in health care outcomes (Lor, Xiong,
Schwei, Bowers, & Jacobs, 2016). Out of the 37.6 million Spanish-speakers residing in the US,
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at least 47% have reported to not being able to communicate in English “very well” (White,
2015). In Hispanics, LEP has been linked to higher rates of miscommunication, less patient
satisfaction due to the inability of clinicians to provide patient-centered care, reduced medication
adherence, and increased medication side effects due to the inability of LEP patients to fully
understand the proper use of medications (White, 2015). As mandated by Title VI of the Civil
Rights Act of 1964, all federally funded programs are required by law to implement meaningful
access to care for patients with LEP (Schwei et al., 2016). In 2000, the US Department of Health
and Human Services, Office of Minority Health, developed the National Standards for Culturally
and Linguistically Appropriate Services in Health and Health Care (CLAS Standards) (The
National CLAS Standards, n.d.). The goal of the CLAS Standards is to promote high quality
health care and enhance health equity for the increasingly diverse minority groups in the US. The
CLAS standards were most recently updated in 2013 and include 15 action steps that work as a
framework to assist clinicians and health care organizations in providing the most culturally and
linguistically appropriate care to minority patients (The National CLAS Standards, n.d.). Despite
the provisions put in place by this law, LEP patients continue to receive poor quality health care.
A major factor contributing to this dilemma is that the meaningful access to care privileges for
LEP patients have not been extensively advocated within the health care system and many
providers continue to lack the knowledge of its effectiveness towards improving health outcomes
(Schwei et al., 2016). Furthermore, when caring for patients with LEP, longer office visit times
need to be allocated to ensure appropriate translation of health information and to allow for
complete understanding of information provided, both by the patient and the provider. This
becomes especially challenging for clinics with high patient loads (McQuaid & Landier, 2017).
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Research has shown that when compared with English proficient patients, those with LEP are
often offered fewer healthcare resources, including interpreter services. Other studies have
reported that when professional interpreter services are utilized for LEP patient visits, healthcare
providers are often inattentive and not entirely supportive to the needs of their LEP patients
(McQuaid & Landier, 2017).
In Hispanic patients with asthma, effective communication between patient and provider
has been associated with improvement in the chronic management of asthma symptoms (Carlin,
Yee, Fagnano, & Halterman, 2014). LEP has also been linked to reduced medication adherence
in this population. Medication adherence plays a crucial role in the effective, long-term
management of chronic diseases such as asthma, with a lack of treatment adherence leading to
reduced asthma outcomes and unnecessary accumulation of healthcare costs (White, 2015).
McQuaid and Landier (2017), defined adherence as the “extent to which a person’s behavior (in
terms of taking medications, following diets, or executing other lifestyle changes) coincides with
the clinical prescription” (p. 200). The process of successful adherence to medication includes
three phases: initiation, implementation and discontinuation. During the initiation phase, the
healthcare provider prescribes a medication and provides adequate information regarding the
benefits and proper use of the medication to the patient and their family. The implementation
phase involves the patient taking the prescribed medication according to the directions provided
by their provider. Subsequently, in the discontinuation phase, the patient is expected to complete
the prescribed course of medication without stopping prematurely (McQuaid & Landier, 2017).
Low levels of health literacy within the Hispanic population have been associated with reduced
medication adherence and incorrect use of prescribed medication (Sarkar et al., 2016). The
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effects of culture are thought to play a pivotal role in how a Hispanic patient perceives the need
to adhere to their medication regimen (McQuaid, 2018). Previous research has revealed that due
to differences in sociocultural background, Hispanic patients are more fearful of their healthcare
providers, are more hesitant to utilize healthcare services for the management of their asthma,
have higher levels of concern regarding the use of their controller medications, and have lower
levels of trust in the health care system (Ahmed & Bates, 2017; McQuaid, 2018). A majority of
Hispanic patients belong to low-income households, have lower levels of education, lack health
insurance, and do not have a stable healthcare provider, and a place to receive routine care (De
Jesus & Xiao, 2014). In addition to LEP, these factors hinder their access to health care services
for the management of persistent asthma.
Problem Statement
It is widely accepted in the literature that LEP leads to significant reductions in health
outcomes. Improvements in patient-provider communication can lead to increased patient
satisfaction and better management of chronic illnesses. According to the asthma management
guidelines developed by the National Heart, Lung and Blood Institute (NHLBI), the
effectiveness of the communication between a patient and their healthcare provider is one of the
major factors associated with improved treatment adherence and the chronic management of
asthma symptoms (Carlin et al., 2014).
Although LEP is a prevalent healthcare issue affecting the Hispanic population in the US,
there remains a continued discrepancy in the data pertaining to its effects on Hispanic adults with
moderate to severe persistent asthma. As reported by the US Census Bureau, 44% of Spanishspeakers were found to have some level of LEP in 2010 (Riera et al., 2015). With the continued
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growth observed in the Hispanic population, it is imperative that further research be conducted to
reduce the current gaps in the literature, and assist clinicians in providing effective, high quality,
culturally competent, and satisfactory care that will relieve the current burdens of asthma
management faced by this under-studied group (Sofianou et al., 2012).
Purpose
There are discrepancies in the current literature regarding the adverse effects of LEP in
Hispanic adults with moderate to severe persistent asthma. With the Hispanic population steadily
on the rise, added research is imperatively required to establish effective interventions that will
advance the future delivery of asthma care and diminish the barriers imposed by the presence of
LEP (Schwei et al., 2016). The intent of this research study, therefore, is to determine if the
presence of LEP is associated with medication adherence behaviors and adverse asthma
outcomes in Hispanic adults aged 18 to 65 years old with moderate to severe persistent asthma,
living in the Tulare and Kings counties of California.
Theoretical model
The Purnell Model for Cultural Competence was developed by Larry Purnell in 1995
(Purnell, 2019). This model will be used as the theoretical and conceptual framework for this
project. It will serve as a structural guide during the research study to highlight the influence of
the Hispanic culture on adult patients with LEP. This includes the effect of cultural beliefs on
patients’ perception of asthma, adherence to asthma medications, and their level of satisfaction
with asthma outcomes. For the past 20 years, the Purnell model has been used extensively in
both the healthcare and various other professional settings to promote culturally competent and
culturally congruent care. While proving its effectiveness as a guide to promote cultural
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competence, the Purnell model has also proved useful in other analogous areas of healthcare
such as language interpretation and documentation translation (Butts & Rich, 2018; Purnell,
2019). Within the model, there are 12 different domains that form the organizing framework
(Purnell, 2019). The Communication domain, especially, relates to the concepts of “dominant
language, health literacy, paralanguage variations, and use of nonverbal communications” (Butts
& Rich, 2018, p. 580). In addition to its usefulness in providing culturally competent care to
Hispanic patients with LEP, the assumptions of the Purnell model closely align with the intention
of this study. These assumptions, specifically, include:
(a) if patients are coparticipants in their care and have a choice in health- related goals,
plans, and interventions, their compliance and health outcomes will be improved; (b)
culture has a powerful influence on one’s interpretation of and responses to health care;
(c) caregivers who assess, plan, intervene, and evaluate in a culturally competent manner
will improve the care of patients for whom they care; and (d) to be effective, health care
must reflect the unique understanding of the values, beliefs, attitudes, lifeways, and
worldviews of diverse populations and individual acculturation patterns. (Purnell, 2019,
p. 98-100)

!8

CHAPTER 2: LITERATURE REVIEW
Review of the Literature
An extensive review of literature was conducted on the adverse effects of LEP on asthma
outcomes and medication adherence in adult Hispanics of the Kings and Tulare counties in
California. The California State University, Fresno’s online research database [Henry Madden
Library] was used to conduct an online search for related research articles. A combination of key
words and phrases used to search for relevant articles included: asthma; California; Tulare
county; Kings county; Hispanic; Hispanic adult; limited English proficiency; LEP; health
literacy; persistent asthma; and moderate and severe persistent asthma.
1. Apter et al. (2013) conducted a study to assess the relationship between health literacy
and subsequent asthma self-management, as measured by adherence to inhaled corticosteroids
(ICS) and asthma outcomes. This study was designed as a prospective longitudinal cohort study
within a large randomized controlled trial. It consisted of 284 adults, aged 34-62 years old, with
moderate or severe persistent asthma who either spoke English or Spanish as their primary
language. The participants were recruited from practices located in low-income, inner city
neighborhoods throughout Pennsylvania and Philadelphia, with a high prevalence of asthma
morbidity. An initial study was conducted to compare individual problem-solving strategies to
standard asthma education. Subsequently, in a 26-week trial, data was collected to electronically
monitor adherence and asthma clinical outcomes, including variables for asthma control, asthma
related quality of life, and Forced Expiratory Volume in one second [FEV1] (Apter et al., 2013).
There was no difference in outcome noted within the randomized groups. Six months later, a
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secondary assessment was performed using the randomized assignment of literacy
questionnaires. These results were used to analyze the relationship between adherence and
asthma outcomes. Health literacy was measured by the means of an asthma-related numeracy
and reading comprehension, or by using print literacy. An evaluation was then conducted to
explore whether participants would benefit from the individual problem solving strategy
intervention by literacy level, and whether the negative association between low literacy levels
and adherence and asthma outcomes would become reduced through the use of individual
problem solving strategies. Findings from this study concluded that interventions aimed to
address the literacy needs of patients may improve asthma outcomes. Furthermore, in order to
achieve better asthma outcomes, healthcare providers were recommended to consider the health
literacy level of their patients. The longitudinal design of this study added to its overall strength
while the five month duration of the study proved to be a limitation (Apter et al., 2013).
2. Riera et al. (2014) conducted a qualitative study to explore how asthma health
communication and asthma action plan delivery are perceived and experienced by LEP
caregivers. The study consisted of 20 Latino asthma health caregivers with LEP who provided
regular asthma care to children 2-12 years old in New Haven, Connecticut. While all the
participants had similar demographic characteristics, individuals both with and without an
asthma action plan were included in the study. Data was gathered over a period of eight months
using qualitative, semi-structured, one-to-one, and in-depth interviews in Spanish. The data was
then systematically analyzed using the constant comparative method. Data triangulation was
subsequently performed via a qualitative focus discussion group. A grounded theory approach
was used to code and analyze the data (Riera et al., 2014). The findings of the study concluded
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that Hispanic LEP caregivers encountered significant burdens associated with their children’s
asthma management, and experienced frequent ineffective communication with their healthcare
providers. The researchers recommended effective communication, empathetic communication
strategies, comprehensive action plans, and improvement in the availability of educational
opportunities for Hispanic patients with LEP as possible solutions. The inclusion of various
ethnic sub-groups from both ambulatory and acute care settings was the key strength of this
study while adoption of a community-based approach limited its generalizability to similar
populations from different geographical locations (Riera et al., 2014).
3. Carlin et al. (2014) conducted a research study to assess the influence of Hispanic
ethnicity on parent-provider communication, and the level of caregiver confidence in
communicating with their child’s healthcare provider during an office visit. The data for this
research was obtained from a larger study, The Prompting Asthma Intervention in RochesterUniting Parents and Providers (PAIR-UP) RTC in Rochester, New York. One hundred and sixtysix caregivers of children aged 2-12 years old with persistent or poorly controlled asthma were
recruited to complete surveys in 12 urban primary care offices. Hispanic ethnicity was
determined through self-report by asking the caregivers whether they considered themselves to
be Spanish, Hispanic, or Latino. Data was collected both in English and Spanish, initially at the
office visit and then two weeks later over the phone. During the phone survey, each caregiver
was asked to provide their perception of their communication with the provider, their degree of
satisfaction, and their overall confidence in their ability to communicate with the healthcare
provider. Findings from the study showed that overall, most caregivers found their interaction
with their providers to be a positive experience. It was concluded that Hispanic caregivers may
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experience better parent-provider communication than non-Hispanic caregivers. The major
strength of this study was the ability of the researchers to obtain the parents’ perception of their
communication with the provider within a two week period, as this reduced the possibility of a
recall bias. The major weakness of the study was its small sample size which may have limited
the power to detect a difference in overall data (Carlin et al., 2014).
4. Sarkar et al. (2016) sought to determine how health care outcomes were affected by
varying levels of health literacy and English proficiency present among Hispanic subgroups. The
study was conducted over a two-month period and consisted of 4,013 nationally recruited
participants aged 18 years and older. During a phone interview, conducted in either English or
Spanish, each participant self-reported their level of health literacy via a three-item health
literacy assessment. The score of this assessment was used to categorize each participant as
having either “adequate” or “inadequate” health literacy (Sarkar et al., 2016). The language
proficiency of the participants was assessed using the Pew Hispanic Healthcare report and their
responses were coded as Spanish speaker, Spanish reader, English speaker, and English reader,
respectively. Acculturation of the participants was measured using the Pew Hispanic Healthcare
Survey. Additional information obtained included health outcomes, demographic variables, and
comorbidity status of the participants. Despite the presence of LEP, a positive correlation was
noted between health literacy and healthcare outcomes of bilingual and Spanish dominant
speakers. The study findings revealed that elevated levels of inadequate health literacy exists
within all Hispanic subgroups (English-dominant, bilingual, and LEP). Additionally, across all
English proficiency levels, individuals with higher levels of health literacy were more likely to
report increased levels of healthcare satisfaction when compared to those with lower levels of
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health literacy. This study concluded that Hispanic patients with higher levels of health literacy
were less likely to utilize traditional methods of health care treatment when compared to
Hispanics with lower levels of health literacy. Due to the large number of nationally recruited
participants, the findings of this study could be generalized to the Hispanic population across the
US. The assessment of health literacy via participant self-report was noted as one of the
limitations of this study (Sarkar et al., 2016).
5. Soones et al. (2016) sought to “describe the causal pathway linking health literacy to
medication adherence by modeling asthma illness and medication beliefs as mediators” (p. 804).
The data for this research was adopted from the Asthma Beliefs and Literacy in the Elderly
study. The study consisted of 433 participants, aged 60 years and older, who were either English
or Spanish speaking, and had moderate to severe persistent asthma. The participants were
recruited from the hospital and community-based primary and pulmonary care clinics in New
York and Chicago from December 2009 to May 2012. In-person interviews were conducted in
either English or Spanish to obtain information regarding the socioeconomic characteristics of
each participant. Health literacy was assessed using the Short Test of Function Health Literacy in
Adults (S-TOFHLA) and scores were categorized as having either adequate or limited health
literacy. Participants’ beliefs regarding asthma and medications were assessed with the Belief
Illness Perceptions Questionnaire (B-IPQ). Cognitive function in older participants was assessed
using tests from the Alzheimer’s Disease Centers’ Uniform Data Set. Medication adherence in
participants was measured using the Medication Adherence Rating Scale (MARS) (Soones et al.,
2016). The findings of this study concluded that the correlation between limited health literacy
and low adherence to asthma controller medication was partially associated with beliefs about
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medications. The researchers recommended that improved asthma outcomes could be achieved if
healthcare providers paid attention to patients’ concerns regarding medication beliefs and used
simplified language when caring for patients with low health literacy levels and cognitive
impairment. The key strength of this study was the use of a the structural equation model to
determine the relationship between health literacy, illness, and medication beliefs, and cognitive
function and medication adherence. The findings of this study were limited by its lack of
generalizability to younger individuals with moderate to severe persistent asthma, and by the
exclusion of individuals living in rural areas (Soones et al., 2016).
6. In light of the rapidly increasing Latino population in the US, Bohm and Cupertino
(2014) conducted a study of rural hospitals to determine the language accommodation methods
utilized by these hospitals when providing care for their patients. According to Title VI of the
Civil Rights Act of 1964 and the CLAS Standards, the provision of language access services for
patients with LEP is federally mandated. Rural hospitals, due to their lack of resources, are
mostly challenged when having to provide language translation services for their Spanishspeaking patients (Bohm & Cupertino, 2014). A ten-item survey was constructed by the
researchers and mailed out to 153 rural hospitals in Kansas and Missouri. The survey included
information regarding the monthly volume of LEP Spanish-speakers at each hospital. These
hospitals were inquired about their use of translated documents such as “advertisement of
language services, educational material, consent forms, complaint forms, preparation information
for procedures and diagnostic tests, and discharge instructions” (Bohm & Cupertino, 2014, p.
1278). Each hospital was asked about their interpretation methods including “bilingual family
members, clinical bilingual staff, non-clinical bilingual staff, staff interpreters, contract
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interpreters, telephonic interpreters, or volunteer interpreters” (Bohm & Cupertino, 2014, p.
1278). The participants were asked to rate their hospital on a 1-10 scale based upon how well
they believed care was being provided to the Spanish-speaking patients. The remainder of the
survey consisted of open-ended questions about any contemporary strategies or obstacles faced
by each hospital in their care of LEP patients (Bohm & Cupertino, 2014). Results of the survey
indicated that most rural hospitals treated approximately 0-5 LEP patients each month. Nearly
71% of the hospitals surveyed used at least one type of translated document, although the
hospitals that reported a higher volume of LEP patients were not equipped with forms in Spanish
for preparation procedures and diagnostic tests, discharge instructions, and patient consent.
According to reports, telephonic interpretation, usage of bilingual family members, and usage of
bilingual hospital employees were the three major types of interpretation techniques used by
hospitals, in descending order. The hospitals that treated an extensive number of LEP patients
generally rated themselves higher on the rating scale. Some examples of barriers reported
included a small Latino population, lack of financial resources and availability of bilingual
employees, difficulty providing interpretation services outside business hours, and lack of
understanding of the Latino culture, etc. (Bohm & Cupertino, 2014). The limitations of this study
included a small sample size and self-reported measures to obtain participant information. Based
on the findings, it was concluded that although rural hospitals are modifying their treatment
strategies to accommodate Hispanic patients with LEP, their care provisions remain suboptimal
and continued improvement is necessary to fully comply with the CLAS standards. Furthermore,
hospitals are encouraged to discontinue their use of bilingual family members as interpreters,
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since the likelihood of untrained interpreters to leave out important information or misinterpret
information has been made evident in the literature (Bohm & Cupertino, 2014).
7. Although previous literature supports the fact that patient-provider communication is
associated with improved adherence to asthma medications, the definitive understanding of this
communication pathway remains unclear. Young et al. (2016) conducted a cross-sectional survey
study to determine the nuances of the communication pathway that lead to enhancement in
patients’ use of their asthma medications. The survey was designed categorically to assess
“patient-provider communication, proximal outcomes, medication adherence, and demographic
characteristics” (Young et al., 2016, p. 697). The participants of the study (n = 452) were
recruited through an online survey delivery and participant recruitment service. The participants
were permitted eligibility to complete the survey if they reported to be more than 18 years old,
were clinically diagnosed with asthma, and were prescribed a preventative or rescue medication
for asthma within the past year. The findings of the study concluded that while there was a
positive and direct link between patient-provider communication and “patients’ understanding of
asthma self-management, agreement with providers, trust, involvement in care, and motivation”,
there was a positive but indirect link between patient-provider communication and adherence to
asthma medication (Young et al., 2016, p. 700). Among the findings of the study, disparities in
asthma self-management were noted in patients from different racial/ethnic groups and
educational levels. The Hispanic/Latino patients, mainly, were found to have decreased levels of
asthma self-management knowledge when compared to their Caucasian counterparts.
Furthermore, Hispanic patients with a high school diploma were found to be less knowledgeable
than those with a college degree. The effects of race/ethnicity and educational level on the self!16

management of asthma were found to be prominent factors leading to long-term disparities in
patients’ asthma outcomes. While “written action plans, self-monitoring, and regular medical
reviews” (Young et al., 2016, p. 700) were some of the interventions proposed by the researchers
to mitigate the effects of racial and educational variations, additional research has been
recommended to explore the roles played by culture and primary language spoken by patients
from different racial/ethnic and educational backgrounds, and their association with asthma selfmanagement (Young et al., 2016). The major limitations of this study included the use of a crosssectional study design and a self-reported survey to gather information from participants. In
addition, the severity of asthma in each participant was not controlled for and the participants
were recruited from an online recruitment service. These factors decreased the generalizability of
the study findings by excluding patients who do not have access to the internet (Young et al.,
2016).
Gaps in the Literature
After extensive review of the effects of LEP on asthma outcomes and medication
adherence in the Hispanic adults of the Kings and Tulare counties, some essential discrepancies
were identified in the existing literature. There is limited information available in the current
literature pertaining to the effects of LEP in adult Hispanics who have moderate to severe
persistent asthma. Although misdiagnosis and under-treatment of asthma is frequently observed
in older patients, an exceeding amount of the data available is based either on studies conducted
on Hispanic children with asthma, or their caregivers who have LEP (Sofianou et al., 2012). A
majority of these studies focus on Hispanics living in larger cities or urban areas. Thus, their
findings cannot be generalized to the Hispanic population residing in the rural areas of
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California. Considering the rapid increase in the Hispanic population in the US, these
discrepancies in the literature require a compelling need for further research to ensure future
provision of quality asthma care and improvement in asthma outcomes in this under-studied
population. Research studies focusing on adult Hispanics with LEP will also contribute towards
educating healthcare providers about the cultural and health care needs of this population,
promote medication adherence and self-management of asthma, improve asthma outcomes, and
enhance effective patient-provider communication.
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CHAPTER 3: METHODOLOGY
Participants and Setting
This study focuses on the adult Hispanic residents of the Kings and Tulare counties in
California. The potential participants for this study will be recruited via a convenience sampling
method from two Baz Allergy, Asthma & Sinus Center clinics located in Hanford and Visalia.
The potential participants will be identified using information obtained from their electronic
medical record (EMR). This quantitative pilot study will consist of 50 patients of Hispanic
descent, aged 18 to 65 years old, with a clinically confirmed diagnosis of moderate or severe
persistent asthma. One group of 25 participants will be proficient in English while the remaining
half will have LEP. To be eligible for inclusion in the study, each participant has to be: (a)
between the ages of 18 to 65 years old; (b) of Hispanic descent; (c) either English or Spanish
speaking, or bilingual; and (d) have a clinically confirmed diagnosis of moderate or severe
persistent asthma. Any participant who does not meet this eligibility criteria, has chronic
obstructive pulmonary disease (COPD) or other chronic pulmonary disease, or has more than a
10-pack-per-year history of smoking, will be excluded from the study. All participants identified
for the study will be established patients of the clinic and therefore, be familiar with the staff,
providers, and the clinic procedure protocols. The potential participants will be approached
during their office visit and invited to volunteer as participants in the study. Data for this study
will be collected over a span of 4 months, from October, 2018 to February, 2019. Prior to data
collection, a consent form, which includes the purpose and protocol of the study, will be
reviewed in detail with each participant and signed. The English or Spanish version of the
consent form will be used based on the participants’ language preference (see Appendices A and
!19

B). Any individual incapable of providing an in-person written consent for the study due to
unwillingness or health limitations, will be excluded from participating in the study. Two sets of
data will be collected from the same participants at three month intervals; the first set from
October to November, 2018, and the second set from January to February, 2019. The clinic
where each participant will provide their information will depend on where they had established
care prior to the study. This location will remain consistent throughout the duration of the study.
Information will be gathered in either English or Spanish, based on the participants’ language
preference. For this study, two trained, bilingual medical assistants from each office will be
assigned to assist with language translation and data collection.
Measures
Information regarding English proficiency, health literacy, sociodemographic
characteristics, asthma history, and chronic comorbid conditions will be obtained at the initial
visit. The level of English proficiency, sociodemographic characteristics, and asthma history will
be obtained verbally through self-report. The level of health literacy of each participant will be
assessed using the Short Test of Functional Health Literacy in Adults (S-TOFHLA) (Baker,
Williams, Parker, Gazmararian, & Nurss, 1999; Wisnivesky et al., 2012) (see Appendices C and
D). Assessments for asthma outcome and medication adherence will be completed at the initial
visit, and then at a three month interval. Asthma outcome measurements will be assessed with
the Asthma Control Questionnaire (ACQ) (Juniper, 2004; Wisnivesky et al., 2012) (see
Appendices E and F) and the Asthma Quality of Life Questionnaire (AQLQ) (Juniper, 1991;
Wisnivesky et al., 2012) (see Appendices G and H). Medication adherence will be assessed using
the Medication Adherence Rating Scale (MARS) (Thompson, n.d.; Apter et al., 2013;
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Wisnivesky et al., 2012) (see Appendix I and J). The English or Spanish version of each
questionnaire will be used, based on the participants’ language preference. For the purpose of
this study, the consent form and the MARS questionnaire were translated into Spanish by a
certified language translator.
English proficiency
During the initial visit, each participant will be evaluated for their level of English
proficiency. Each participant will be asked to verbally categorize their primary language as
English, Spanish, or both. The participants who report Spanish as their primary language will
then be asked to classify their ability to speak and understand English as very poor, poor, fair,
good, very good, or excellent. Participants who rate their ability to speak English as very poor,
poor, or fair, will be categorized as having LEP. The remaining participants will be classified as
having English proficiency (EP) (Wisnivesky et al., 2012).
Asthma outcomes
The asthma outcomes for participants will be measured twice using an ACQ and an
AQLQ. Both of these questionnaires have been previously validated in both English and Spanish
(Juniper, O’Byrne, Guyatt, Ferrie, & King, 1999; Juniper, Buist, Cox, Ferrie, & King, 1999;
Wisnivesky et al., 2012). The ACQ is a 7-item questionnaire used to measure asthma control.
The questionnaire includes questions about the five most important asthma symptoms, the
frequency of the albuterol inhaler use, and the FEV1% predicted value of the spirometry test. The
responses gauge the participants’ asthma control over the past week. The final score is the mean
score of all the responses. A score of 0 is indicative of well-controlled asthma whereas a score of
6 indicates highly uncontrolled asthma. For the purpose of this study, the optimal cut-point will
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be 1.50. If a participant’s mean score on the questionnaire is ≥ 1.50, this means that there is an
88% or higher chance that their asthma is not well-controlled (Juniper, 2004). The AQLQ will be
used to analyze asthma-related quality of life. The questionnaire has a recall period of two weeks
and determines the participants’ overall well-being by asking questions about lifestyle issues
commonly related to asthma. The questionnaire consists of 32 items grouped into 4 categories:
activity limitations, symptoms, emotional function, and environmental stimuli. Each question has
a 7-point response scale ranging from 1 (severe impairment) to 7 (no impairment). The final
score is the mean score of the 32 responses (Juniper, 2010; Apter et al., 2013; Wisnivesky et al.,
2012). For the purpose of this study, a score of 1.0 to 3.0 will be categorized as a severe
impairment, a score of 3.1 to 5.0 will be categorized as a moderate impairment, and a score of
5.1 to 7.0 will be categorized as having no impairment on asthma-related quality of life. The
spirometry testing will be performed according to the recommendations set forth by the
American Thoracic Society (ATS) to assess lung function (ATS, 2017). Indices for FEV1prebronchodilator, FEV1predicted, and FEV1%predicted will be recorded for each participant
initially, and then at a three month interval, as part of question number seven of the ACQ
(Juniper, 2004; Apter et al., 2013; Culver et al., 2017).
Medication adherence
The lack of medication adherence in Hispanic patients with LEP has been associated with
impaired asthma outcomes (White, 2015). The MARS will be used to assess for controller
medication adherence in participants (Thompson, n.d.). As part of this study, asthma controller
medications will consist of inhaled corticosteroids (ICS), long-acting beta agonists (LABA),
long-acting muscarinic antagonists (LAMA), and leukotriene receptor modifiers. MARS is a
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validated measuring scale consisting of 10 items used to assess for medication adherence. Each
of the 10 items will be scored based on a 5-point Likert Scale where higher scores are indicative
of better medication adherence (Thompson, Kulkarni, & Sergejew,
2000; Wisnivesky et al., 2012, p. 180). For the purpose of this study, the participants with a total
score of ≥ 5 will be categorized as being compliant with medication adherence and those with a
score of ≤ 5 will be categorized as being non-compliant.
Covariates
Health literacy
Previous research has confirmed that elevated levels of inadequate health literacy does
have an association with adverse asthma outcomes and decreased medication adherence (Apter et
al., 2013; Sarkar et al., 2016; Wisnivesky et al., 2012). The S-TOFHLA will be used to measure
the level of health literacy in the participants (Nurss, Parker, Williams & Baker, 2001). This tool
has been previously validated for use in research and is available in both English and Spanish
(Baker et al., 1999). The S-TOFHLA consists of 36-items, with the final score being the total
number of items that were answered correctly (Apter et al., 2013; Wisnivesky et al., 2012). For
the purpose of this study, the participants with a score of 0 to 16 will be identified as having
inadequate functional health literacy. The participants with scores between 17 to 22 will be
placed in the marginal functional health literacy category, and those with a score of 23 to 36 will
be categorized as having adequate functional health literacy (Nurss et al., 2001).
Alternative variables
The data on alternative variables will be collected via self-report as part of the
participants’ baseline characteristics at the initial visit. These will include sociodemographic
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information (age, sex, annual income, and the level of education), asthma history (the number of
years since diagnosis of asthma, history of intubation, current oral steroid dependency, and recent
treatment with oral steroids), and other chronic health conditions (allergy, eczema, sinusitis,
gastroesophageal reflux disease (GERD), diabetes, hypertension,
congestive heart failure (CHF), osteoporosis, and obesity) (Sarkar et al., 2016; Soones et al.,
2016; Wisnivesky et al., 2012). The raw data will be coded and categorized prior to statistical
analysis. The age of the participants will be categorized in years as: 18-29; 30-39; 40-49; 50-59;
and 60-65. The sex of the participants will be categorized as: male; female. The annual income
of the participants will be categorized as: ≤ $20,000; $20,000-$34,999; $35,000-$49,999;
$50,000-$74,999; $75,000-$99,999; and ≥ $100,000. The level of education will be categorized
as: ≤ high school; high school or equivalent; some college, no degree; associates degree;
bachelor’s degree; master’s degree; and doctoral degree. The number of years since the diagnosis
of moderate or severe persistent asthma will be categorized into years as: 0-5; 6-10; and ≥ 11yrs.
Statistical Analysis
The data obtained during this study will be analyzed using the SPSS® Statistics, Version
24.0 software. A descriptive correlational analysis using the chi-square test will be used to
interpret the relationship between the categorical variables. A frequency distribution statistics test
will be used to identify the occurrence of values within the various test intervals. The
aim of the statistical analysis will be to identify if there is a statistically significant correlation
between the level of English proficiency, asthma outcome (asthma control and asthma quality of
life) and the medication adherence variables. The covariate variables (health literacy,
sociodemographic variables, asthma history, and chronic comorbidities) will also be compared
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with the level of English proficiency to assess for the existence of a significant correlation
between the variables. A statistically significant relationship between the variables will be
confirmed based on a p-value of ≤ 0.05 (Knapp, 2017).
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CHAPTER 4: RESULTS
Baseline Population Characteristics
From October to November 2018, 37 patients were recruited to participate in the research
study from the Baz Allergy, Asthma & Sinus Center clinics located in Hanford and Visalia,
California. Twenty-five of the participants were English-proficient, while the remaining 12 had
LEP. These participants were identified for the study based on the clinics’ EMR database.
Participants were approached for consent to participate in the study if they were (a) between the
ages of 18 to 65 years old; (b) of Hispanic descent; (c) either spoke English, Spanish, or both;
and (d) had a clinically confirmed diagnosis of moderate or severe persistent asthma. While
reviewing patients EMR information, the patients who were of non-Hispanic descent, outside 18
to 65 years of age, had COPD or other chronic pulmonary disease, and had more than a 10 packper-year history of smoking, were excluded. The SPSS® Statistics, Version 24.0 software was
used to conduct statistical analyses on the data collected. The aim of the research study, initially,
was to collect two sets of data on the participants, with an interval of three months in between.
The data was scheduled to be collected from October to November of 2018 (Round 1) and then
from January to February of 2019 (Round 2). Due to unforeseen time constraints, only one set of
data, from October to November of 2018, was successfully gathered. The second round of
collection was attempted in January of 2019 but not enough data could be compiled to conduct a
meaningfully significant statistical analysis.
Table 1 includes the baseline characteristics of all participants enrolled in the study based
on their level of English proficiency. The variables for the baseline population characteristics
included sociodemographic characteristics (age, gender, annual income, and the highest level of
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Table 1
Baseline Characteristics of Participants Associated with English Proficiency
Characteristic

Total (%)
(n=37)

EP (%)
(n=25)

LEP (%)
(n=12)

p-value

Age, years (%)
18-29
30-39
40-49
50-59
60-65

4 (10.8)
9 (24.3)
6 (16.2)
9 (24.3)
9 (24.3)

4 (16.0)
8 (32.0)
4 (16.0)
5 (20.0)
4 (16.0)

0 (0.0)
1 (8.3)
2 (16.7)
4 (33.3)
5 (41.7)

Sex (%)
Male
Female

12 (32.4)
25 (67.6)

9 (36.0)
16 (64.0)

3 (25.0)
9 (75.0)

Annual income (%)
≤ $20,000
$20,000-$34,999
$35,000-$49,999
$50,000-$74,999
$75,000-$99,999
≥ $100,000

19 (55.9)
2 (5.9)
3 (8.8)
7 (20.6)
2 (5.9)
1 (2.9)

8 (36.4)
2 (9.1)
2 (9.1)
7 (31.8)
2 (9.1)
1 (4.5)

11 (91.7)
0 (0.0)
1 (8.3)
0 (0.0)
0 (0.0)
0 (0.0)

Education (%)
≤ High school
High school or equivalent
Some college, no degree
Associates degree
Bachelor’s degree
Master’s degree
Doctoral degree

13 (35.1)
6 (16.2)
10 (27.0)
3 (8.1)
3 (8.1)
2 (5.4)
0 (0.0)

2 (8.0)
5 (20.0)
10 (40.0)
3 (12.0)
3 (12.0)
2 (8.0)
0 (0.0)

11 (91.7)
1 (8.3)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)

Asthma history (%)
Ever intubated
Steroid dependent
Oral steroid treatment within 3 months

0 (0.0)
0 (0.0)
6 (16.2)

0 (0.0)
0 (0.0)
4 (16.0)

0 (0.0)
0 (0.0)
2 (16.7)

N/A
N/A
1.000

Years with asthma (%):
0-5 yrs
6-10 yrs
≥ 11yrs

11 (29.7)
9 (24.3)
17 (45.9)

4 (16.0)
8 (32.0)
13 (52.0)

7 (58.3)
1 (8.3)
4 (33.3)

0.025*

Self-reported chronic conditions (%)
Allergy
Eczema
Sinusitis
Gastroesophageal reflux disease (GERD)
Diabetes
Hypertension
Congestive heart failure (CHF)
Osteoporosis
Obesity

37 (100.0)
5 (13.5)
2 (5.4)
13 (35.1)
8 (21.6)
11 (29.7)
0 (0.0)
0 (0.0)
27 (73.0)

25 (100.0)
3 (12.0)
2 (8.0)
7 (28.0)
3 (12.0)
5 (20.0)
0 (0.0)
0 (0.0)
18 (72.0)

12 (100.0)
2 (16.7)
0 (0.0)
6 (50.0)
5 (41.7)
6 (50.0)
0 (0.0)
0 (0.0)
9 (75.0)

N/A
1.000
1.000
0.274
0.083
0.122
N/A
N/A
1.000

Health literacy (%)
Inadequate functional health literacy
Marginal functional health literacy
Adequate functional health literacy

7 (18.9)
2 (5.4)
28 (75.7)

1 (4.0)
1 (4.0)
23 (92.0)

6 (50.0)
1 (8.3)
5 (41.7)

0.092

0.711

0.013*

0.000*

0.003*

Note. EP - English Proficient; LEP - limited English proficiency. n - sample size. * - significant p-value (p ≤ 0.05).
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education), asthma history (history of intubation, current oral steroid dependence, history of oral
steroid exposure within the past three months, and the number of years with asthma), and the
level of functional health literacy. A frequency distribution statistics test was used to measure the
occurrence of the baseline characteristic variables within the overall population, based on the
level of English proficiency. The chi-square test was used to determine if a significant correlation
existed between the categorical variables of the baseline characteristics and the level of English
proficiency. If the test between two variables did not meet the chi-square pre-test criteria (1 - n ≥
5 per cell minimum) (Knapp, 2017), the Pearson’s chi-square coefficient was not used to
determine the significance of the relationship between the variables. In this case, the Fisher’s
exact test coefficient was used if the 2 x 2 table criteria was met. If the test failed to meet the
criteria for both the chi-square test and the Fisher’s exact test, then the likelihood ratio was used
to analyze the relationship between the variables (Knapp, 2017).
In the EP group, a majority of the patients were between the ages of 30 to 39 years old
(32%) while in the LEP group, most patients were between the ages of 50 to 65 years old (75%).
There were more female participants in the study compared to males; 64% of the participants in
the EP group and 75% of those in the LEP group were female. There was no significant
relationship between the age and gender of the participants and their level of English proficiency
(p-value 0.09 and 0.71, respectively). Overall, nearly 56% of the participant population earned ≤
$20,000 per year. Within both the EP and LEP groups, the majority of the participants earned less
than $20,000 annually. For the EP group, the second-highest income range was between
$50,000-$74,999 while in the LEP group, the second-highest income range was seen in the
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$35,000-$49,999 range. Three of the 37 participants failed to provide data about their annual
income. A significant correlation was seen between the annual income earned and the level of
English proficiency (p-value 0.01). A majority of the overall population reported having an
education level that was either less than a high school degree or with some college education, but
no degree. For the EP group, 40% of the participants had some college education with no degree,
while 91.7% of the LEP group had a ≤ high school education. A significant relationship was
noted between the participants’ level of education and English proficiency. None of the
participants were steroid dependent or had a history of ever being intubated during an asthma
flare. A similar frequency of oral steroid use was observed for both the EP and the LEP groups
over a period of three months. Overall, nearly 46% of the participants reported having asthma for
≥ 11 years. While 52% of the participants in the EP group reported having asthma for ≥ 11 years,
more than half (58%) of the patients in the LEP group reported a fairly recent diagnosis of
asthma (0-5 years). A significant correlation was observed between the years since the diagnosis
of asthma and the English proficiency level (p-value 0.03) of the participants. No correlation was
noted in the participants’ self-reported chronic comorbidities and their level of English
proficiency. Overall, 73% of the participants were obese; 72% of the EP group was obese while
75% of the LEP participants had a Body Mass Index (BMI) that fell in the obesity range. A
distinct correlation was noted between the level of health literacy and the level of English
proficiency (p-value 0.03). Overall, a majority of the patient population had adequate functional
health literacy (~76%). Within the EP group, 92% of the patients had adequate functional health
literacy while half of the LEP group, had inadequate functional health literacy.
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Table 2
Association of Major Covariates with Asthma Outcomes and Medication Adherence
Outcome
WC

AC (%)
(n=37)
NWC

Annual income (%) *
≤ $20,000
$20,000-$34,999
$35,000-$49,999
$50,000-$74,999
$75,000-$99,999
≥ $100,000

8 (42.1)
2 (100.0)
2 (66.7)
5 (71.4)
2 (100.0)
1 (100.0)

p-vale

0.156

Education (%)
≤ High school
High school or equivalent
Some college, no degree
Associates degree
Bachelor’s degree
Master’s degree
Doctoral degree

6 (46.2)
3 (50.0)
6 (60.0)
2 (66.7)
2 (66.7)
2 (100.0)
0 (0.00)

p-value

0.661

Years with asthma:
0-5 yrs
6-10 yrs
≥ 11 yrs

7 (63.6)
6 (66.7)
8 (47.1)

p-value

0.541

Health literacy (%)
Inadequate FHL
Marginal FHL
Adequate FHL

5 (71.4)
0 (0.00)
16 (57.1)

p-value

0.136

Mi

11 (57.9)
0 (0.00)
1 (33.3)
2 (28.6)
0 (0.00)
0 (0.00)

6 (31.6)
0 (0.00)
1 (33.3)
2 (28.6)
0 (0.00)
0 (0.00)

QoL (%)
(n=37)
Mo
Se
9 (47.4)
0 (0.00)
1 (33.3)
1 (14.3)
0 (0.00)
0 (0.00)

4 (21.1)
2 (100.0)
1 (33.3)
4 (57.1)
2 (100.0)
1 (100.0)

0.179
7 (53.8)
3 (50.0)
4 (40.0)
1 (33.3)
1(33.3)
0 (0.00)
0 (0.00)

5 (38.5)
2 (33.3)
2 (20.0)
1 (33.3)
0 (0.00)
0 (0.00)
0 (0.00)

1 (9.10)
1 (11.1)
8 (47.1)

5 (38.5)
2 (33.3)
3 (30.0)
0 (0.00)
2 (66.7)
0 (0.00)
0 (0.00)

3 (23.1)
2 (33.3)
5 (50.0)
2 (66.7)
1 (33.3)
2 (100.0)
0 (0.00)

2 (28.6)
1 (50.0)
7 (25.0)
0.558

4 (21.1)
0 (0.00)
0 (0.00)
0 (0.00)
1 (50.0)
0 (0.00)

10 (76.9)
5 (83.3)
9 (90.0)
3 (100.0)
3 (100.0)
1 (50.0)
0 (0.00)

3 (23.1)
1 (16.7)
1 (10.0)
0 (0.00)
0 (0.00)
1 (50.0)
0 (0.00)

0.539
3 (27.3)
3 (33.3)
6 (35.3)

7 (63.6)
5 (55.6)
3 (17.6)

0.049**
2 (28.6)
2 (100.0)
12 (42.9)

15 (78.9)
2 (100.0)
3 (100.0)
7 (100.0)
1 (50.0)
1 (100.0)
0.300

0.361
4 (36.4)
3 (33.3)
9 (52.9)

MA (%)
(n=37)
C
NC

7 (63.6)
8 (88.9)
16 (94.1)

4 (36.4)
1 (11.1)
1 (5.90)

0.106
3 (42.9)
1 (50.0)
8 (28.6)

2 (28.6)
0 (0.00)
13 (46.4)

6 (85.7)
1 (50.0)
24 (85.7)

1 (14.3)
1 (50.0)
4 (14.3)

0.517

Note. AC - Asthma Control, WC - well controlled, NWC - not well controlled. QoL - Quality of Life, Mi - mild
impairment, Mo - moderate impairment, Se - severe impairment. MA - Medication Adherence; C - compliant, NC non-compliant. n - sample size. FHL - functional health literacy. * - n = 34 (3 participant responses missing for
annual income), ** - significant p-value with p ≤ 0.05.

Covariates
The baseline population characteristic variables, annual income, level of education, the
number of years with asthma, and health literacy, were noted to have a significant relationship
with the level of English proficiency (p-value ≤ 0.05) (Table 1). These were considered to be the
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major covariates of the study. Table 2 conveys the association of these covariates with the asthma
outcomes (asthma control and asthma quality of life) and medication adherence. These
comparisons were conducted to verify if, in addition to having a significant relationship with the
participants’ level of English proficiency, these baseline characteristics also demonstrated any
notable relationship with their asthma outcomes and medication adherence. The chi-square test
was used to determine if a significant correlation existed when these covariates were compared
with the asthma outcomes and medication adherence variables. As mentioned previously, when
the test failed to comply with the criteria for both the chi-square test and the Fisher’s exact test,
the likelihood ratio was used to interpret the relationship between the variables.
There was no significant correlation noted when the annual income was compared with
the participants’ asthma control, quality of life, and medication adherence. Similarly, the levels of
education and functional health literacy did not demonstrate any significant difference when
compared to asthma outcomes and medication adherence. In both these comparisons, the p-value
was ≥ 0.05, which was indicative of no statistically significant difference between the levels of
these covariates, asthma outcomes and medication adherence. The number of years each
participant had asthma was compared with asthma outcomes and medication adherence. No
significant difference was observed between the number of years with asthma when compared to
asthma control and medication adherence (p-value ≥ 0.05). A p-value of ≤ 0.05 was noted when
the number of years with asthma was compared with the participants’ quality of life. A majority
of the participants (~46%) reported having asthma for ≥ 11 years. Most of the participants
(~41%) reported that asthma severely impaired their quality of life. For the 20 participants who
reported having asthma for ≤ 10 years, the majority (60%) felt that their asthma severely
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impaired their quality of life. In the remaining 17 participants who reported having asthma for ≥
11 years, the majority (47%) felt that asthma caused a mild impairment to their quality of life.
English Proficiency, Medication Adherence and Asthma Outcomes
The goal of this study was to determine if the presence of LEP affected asthma outcomes
(asthma control and quality of life) and medication adherence in Hispanic adults with moderate
to severe persistent asthma. The chi-square test was used to determine if asthma outcomes
(asthma control and quality of life) and medication adherence had a significant relationship to the
level of English proficiency of the participants (Table 3). The likelihood ratio was used to
determine the relationship between the variables if the tests failed to satisfy the criteria
requirements for both the chi-square and the Fisher’s exact tests.
Table 3
Association of English Proficiency with Asthma Outcomes and Medication Adherence
Outcome

EP (%)
(n=25)

LEP (%)
(n=12)

Asthma control (%)
Well-controlled
Not well-1controlled

14 (56.0)
11 (44.0)

7 (58.3)
5 (41.7)

Quality of life (%)
Mild impairment
Moderate impairment
Severe impairment

6 (24.0)
7 (28.0)
12 (48.0)

4 (33.3)
5 (41.7)
3 (25.0)

Medication adherence (%)
Compliant
Non-compliant

21 (84.0)
4 (16.0)

10 (83.3)
2 (16.7)

p-value
1.000

0.396

1.000

Note. EP - English proficient, LEP - limited English proficiency. n - sample size.

The majority of the participants in both the EP and LEP groups were found to have well
controlled asthma and reported adequate compliance with their medications. Forty-eight percent
of the participants in the EP group reported a severe impairment to their quality of life due to
asthma while only 25% of the LEP group felt this way. In the LEP group, ~42% of the
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participants reported moderate impairment and 33% reported a mild impairment to their quality
of life due to asthma. The percentages of participants who reported mild and moderate
impairments to their quality of life due to asthma were essentially comparable within the EP
group. The p-value for the comparisons of asthma control, quality of life, and medication
adherence were all ≥ 0.05. Therefore, it was concluded that there was no statistically significant
difference in asthma outcomes and medication adherence behaviors among the participants in
this study based on the level of their English proficiency.
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CHAPTER 5: DISCUSSION AND CONCLUSION
Discussion
There is considerable data available in the literature linking LEP to reduced health
outcomes. These include but are not limited to decreased access to health care resources,
misunderstanding of medical information and disease process, poor self-management of chronic
illness, medication non-adherence, and subsequent dissatisfaction and mistrust in the health care
system (Schwei et al., 2016; Wisnivesky et al., 2012). In the US, the Hispanic population is a
predominant subgroup that is largely affected by LEP, leading to suboptimal health outcomes
(White, 2015). In Hispanic adults with asthma, the presence of LEP hinders optimal asthma
control and the appropriate use of controller medications caused by miscommunication between
patients and their clinicians (Wisnivesky et al., 2012). As the Hispanic population continues to
grow, there is a compelling need to focus on the existing gaps in the literature and find competent
solutions that will promote asthma outcomes and mitigate the health care burden associated with
LEP. The intent of this study was to explore if the presence of LEP was associated with adverse
asthma outcomes and medication adherence behaviors in Hispanic adults aged 18 to 65 years old
residing in the Kings and Tulare counties of California.
Association of LEP with asthma outcomes and medication adherence
Contrary to previous literature, the findings of this study did not indicate a statistically
significant difference in asthma outcomes (asthma control, quality of life) and medication
adherence in the presence of LEP. Sarkar et al. (2016) reported a significant positive correlation
in health outcomes regardless of the presence of LEP. This finding was concluded from a much
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larger study consisting of over 4,000 nationally recruited participants from various Hispanic
subgroups. In our study, the reports
of asthma control were essentially analogous in both the English proficient (EP) and the LEP
groups (p-value 1.0). A majority of the participants in the EP group described their asthma as
severely impairing their quality of life (48%) while those in the LEP group reported mild to
moderate impairment of their quality of life due to asthma (p-value 0.39). Our study was also
conducted on a much smaller scale which may have restricted its power to identify a significant
discrepancy in the overall participant data. In 2013, Andres et al. reported that insufficient and
erroneous communication can lead to severe health implications for LEP patients. Bohm and
Cupertino (2014) performed a study to explore the language accommodation approaches
practiced by rural hospitals when providing care for patients with LEP. The results of this study
concluded that although adjustments are under way to implement higher quality care for LEP
patients in rural settings, continued efforts are essential to conform to CLAS standards
requirements, and adequately accommodate the increasing healthcare demands of the Hispanic
population. The findings of our study, on the contrary, did not exhibit a statistically significant
discrepancy in the asthma outcomes and medication adherence patterns of the EP and LEP
groups and thus, did not necessitate any further enhancement of the clinics’ pre-established
language accommodation parameters.
Self-management is a fundamental factor in long term asthma control (Wisnivesky et al.,
2012). In LEP patients with asthma, language barriers hinder access to high quality care, reduce
effective communication with providers, lessen the capability to adhere to prescribed medication,
and discourage the self-management of asthma (Andres et al., 2013; Wisnivesky et al., 2012).
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Riera et al. (2014), explored how asthma communication and action plan delivery were
perceived and experienced by Hispanic LEP caregivers with asthmatic children. Results of the
study confirmed that these caregivers were more inclined to engage in ineffective
communication with their healthcare providers and endured considerable burdens related to the
long-term asthma management of their children. The study findings revealed a significant
relationship between the levels of English proficiency and the functional health literacy of the
participants. Previous research has linked both reduced health literacy levels and LEP in
Hispanics to suboptimal medication adherence behaviors and inability to adequately self-manage
asthma (McQuaid, 2018; White, 2015). Based on previous literature, it might be presumed that
the results of this study would demonstrate a direct correlation between medication adherence
behaviors and the level of English proficiency but no statistically significant difference was
identified. For both the EP and LEP groups, essentially similar percentages of medication
compliance were reported (p-value 1.0). Young et al. (2016) conducted a study to investigate the
implications of the communication pathway that promoted improvement in patients’ use of
asthma medication. The study findings confirmed that minority groups such as the Hispanics,
who have lower levels of education, were more likely to experience discrepancies in asthma selfmanagement. Consequently, the influence of race/ethnicity and educational level on the selfmanagement of asthma were recognized as key factors leading to longstanding inconsistencies in
asthma outcomes. Consistent with the findings of this study, a significant correlation between
LEP and the level of education was observed among the Hispanic participants in our study as
well, in conjunction with annual income, number of years with asthma, and the level of
functional health literacy. The majority of the participants in the LEP group reported having an
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educational level of a high school degree or less while 60% of the EP group reported having
either a high school degree (or equivalent) or some college education without a degree.
Furthermore, a significant relationship was identified between the difference in the number of
years with asthma and the asthma quality of life. Most of the participants (~46%) in the study
reported having asthma for more than 11 years. A majority of these participants felt that asthma
caused a mild impairment to their overall quality of life. Out of the 54% of the participants who
reported having asthma for less than 10 years (0-5 years and 6-10 years), 60% felt that their
asthma severely impaired their quality of life. When compared with the level of English
proficiency, most of the EP participants (52%) reported having asthma for more than 11 years
while most of the LEP participants reported having asthma for less than 5 years. Based on these
findings, it can be inferred that a majority of the EP participants felt their asthma had a mild
impairment on their overall quality of life while the LEP patients reported asthma to impair their
lives more severely. Furthermore, as the majority of the LEP patients from our findings reported
being clinically diagnosed with asthma fairly recently, some underlying presumptions that could
be deduced to corroborate this phenomena were that perhaps these patients: (a) lacked regular
access to a primary care provider or clinic where they could receive asthma care; (b) did not have
healthcare insurance; (c) were using alternative or traditional methods of asthma treatment; and
(d) lacked trust in the healthcare system based on their sociocultural barriers.
Association of LEP with health literacy
Previous research concludes that Hispanics, in general, have lower levels of health
literacy compared to any other ethnic minority group (Sarkar et al., 2013). In their study,
Wisnivesky et al. (2012) observed that elderly patients and ethnic minorities had higher rates of
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low health literacy. Based on their findings, it was concluded that an association between LEP,
low health literacy, and asthma outcome could be assumed. The level of functional health
literacy was one of the major covariates observed in our study. While
92% of the EP participants were found to have adequate health literacy, half of the LEP
participants had inadequate health literacy. Consistent with previous literature, our research
findings concluded the existence of a significant difference between the levels of functional
health literacy and English proficiency. Similarly, Sarkar et al. (2016) found out that elevated
levels of inadequate health literacy existed within all Hispanic subgroups. The relationship
between health literacy and health outcomes was not confined to LEP but affected Hispanics
with differing levels of English proficiency, even those who reported being bilingual. On the
contrary, no statistically significant difference was evident in comparisons between health
literacy, asthma outcomes, and medication adherence in our study. From their findings, Apter et
al. (2013) confirmed that health literacy was directly associated with asthma outcomes and
through interventions aimed at improving the health literacy needs of LEP patients, healthcare
providers can promote better asthma outcomes.
Limitations
Our study had some key limitations which may have influenced the final results. The
small size of the representative sample (n = 37) and the LEP group (n = 12) may have reduced
the strength to detect a statistically significant difference in the overall data. Due to unanticipated
time constraints and other contingencies, a second set of data could not be collected by the
researcher as initially planned. The results of the study, therefore, were analyzed based on the
preliminary data. A convenience sampling method was utilized to recruit the participants from
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the two clinics in the Kings and Tulare counties. Thus, our sample population mainly included
Hispanics of Mexican descent while excluding a majority of the other Hispanic subgroups
residing in other geographical locations. The participants in our study were all established
patients under the care of asthma specialists during the study. Therefore, the findings
of this study may not represent Hispanic patients with asthma in alternate healthcare settings that
do not specialize in asthma management or patients who do not have regular access to asthma
care. In addition, the healthcare providers in the clinics were not screened for their level of
cultural competency and no observations were made regarding the effectiveness of the patientprovider communication during the office visits.
Conclusion
The adult Hispanic population in the US is extensively affected by the presence of LEP.
The literature has linked LEP in this population with reduced access to healthcare services,
misunderstanding of health and self-management information, decreased treatment adherence,
ineffective communication with healthcare providers, lower health outcomes, and decline in the
overall quality of care. While abundant research and treatment guideline information is available
for children with asthma, there are indisputable gaps existing in the literature regarding Hispanic
adults with moderate to severe persistent asthma. The purpose of this study was to determine if
the presence of LEP is associated with adverse asthma outcomes and medication adherence
behaviors in Hispanic adults aged 18 to 65 years old with moderate to severe persistent asthma,
residing in the Kings and Tulare counties of California.
Thirty-seven participants were included in the study. Twenty-five of these participants
were EP while the remaining 12 had LEP. Data was collected for asthma control, asthma quality
!39

of life, medication adherence, health literacy, sociodemographic characteristics, comorbidities
and asthma history. Three key findings were observed in our study: 1) we concluded that
contrary to previous literature, there was no statistically significant difference identified between
the level of English proficiency, asthma outcomes (asthma control and asthma quality of life) and
medication adherence behaviors in our population; 2) consistent with previous literature, a
statistically significant correlation was present between the level of English proficiency and the
covariate variables: annual income, level of education, number of years with asthma, and the
level of functional health literacy; and 3) a statistically significant difference was observed
between the number of years with asthma and the asthma quality of life. Participants in the EP
group who were diagnosed more than 11 years ago, reported that asthma had a mild impairment
on their quality of life. Meanwhile, the LEP participants who had asthma for less than five years,
reported that their asthma caused a severe impairment on their quality of life.
Future research
Despite the limitations, the results from this study can be recognized as a fundamental
step towards alleviating the gaps that currently exist in the literature regarding the long-term
asthma outcomes and the medication adherence behaviors of the Hispanic adults who struggle
with LEP. Future research should endeavor to conduct a longitudinal study consisting of a larger
representative sample recruited via a probability sampling method to ensure valid and reliable
conclusions, and to reduce the possibility of bias. The representative sample should also
incorporate various Hispanic subgroups so that the findings from the study can be generalized to
a larger population of adult Hispanics with moderate to severe persistent asthma who have LEP.
Finally, since cultural beliefs play a crucial role in the self-management of asthma and other
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chronic diseases, and the effectiveness of patient-provider communication has shown to improve
long-term asthma outcomes, the inclusion of these variables in future research studies needs to
be considered by researchers.
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APPENDICES
Appendix A: Consent Form
CALIFORNIA STATE UNIVERSITY, NORTHERN CALIFORNIA CONSORTIUM
DOCTOR OF NURSING PRACTICE
CONSENT FORM FOR RESEARCH PARTICIPATION
Study Title: Is there a relationship between limited English proficiency (LEP), medication
adherence behaviors, and adverse asthma outcomes in Hispanic adults with moderate or severe
persistent asthma?
Principal Investigator: Archana Chandra, Nurse Practitioner
Why are you doing this study?
You are being asked to participate in a research study about Hispanic adults with moderate or
severe persistent asthma. The aim of this study is to find out if Hispanic patients who speak
English well have better controlled asthma than Hispanic patients who have difficulty speaking
English.
What will I do if I choose to be in this study?
1. You will be asked to fill out questionnaires about:
• English proficiency- will inform the researcher of how well you Speak English.
• Medication Adherence- will inform the researcher of how often you use your controller
medications for asthma.
• Asthma control- will inform the researcher of how well your asthma is controlled by taking
your current medications.
• Quality of life- will inform the researcher of how satisfied you are with how well your asthma
is controlled and the medications you are taking.
• Health Literacy- will inform the researcher how well you understand health information.
2. You will be asked to do a spirometry function test. This is the same test that you do at every
follow up visit to find out what your lung function is.
3. You will be asked to provider personal information such as age, gender, sex, average income
earned in a year, and level of education.
4. You will be asked to provide information regarding your asthma history such as the number of
years you have had asthma, how often you have asthma flares, how often you have to go the
emergency department, and if you have ever been intubated for a severe asthma flare.
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Study time: Study participation will take approximately 30 to 45 minutes per visit. After the
initial visit, each participant will be asked to follow up at their assigned clinic (Visalia or
Hanford) every 3 months for 6 months. This does not include any sick visits the participant has
to schedule in between the required 3-month visits.
Study location: All study procedures will take place at the Baz Allergy clinics in Visalia and
Hanford. If you are a patient at the Visalia office, you will continue to schedule your visits at the
Visalia office and vice versa. You will not be asked to travel to a different location at any time
during the study.
What are the possible risks or discomforts?
To the best of my knowledge, your participation in this study will not involve any physical or
emotional risk to you beyond that of everyday life. If you feel any emotional or psychological
discomfort at any time during the interview, you may take a break or ask to stop the interview. If
you feel uncomfortable with any of the questions, you may also choose to not answer the
question or skip to the next question.
What are the possible benefits for me or others?
Taking part in this research study may not benefit you personally. This study is designed to learn
more about Hispanic adults with asthma who have difficulty speaking English. The results from
this study will be used to help patients in similar situations to improve the quality of their asthma
care in the future.
As with all research, there is a chance that confidentiality of the information we collect from you
could be breached – we will take steps to minimize this risk. This is discussed in more detail
below in this form.
How will you protect the information you collect about me, and how will that information
be shared?
Results of this study may be used in presentations or publications in the future. Any information
collected from you will be handled with utmost confidentiality. If the results of this study are
presented or published, individual names, contact information, and any other information that
could be used to identify you personally will never be used.
To minimize the risks to confidentiality, each participant will be assigned a number and this
number will linked to their information. Actual names of participants or other personal
information will not be used to represent individual participants. All information will be stored in
a locked cabinet at the researcher’s residence. After the completion of the research study all the
data collected will be shredded and disposed of with utmost care.
We may share the data we collect from you for use in future research studies or with other
researchers – if we share the data that we collect about you, we will remove any information that
could identify you before we share it.
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If we think that you intend to harm yourself or others, we will notify the appropriate people with
this information.
Financial Information
Participation in this study will involve no additional cost to you. Participating in this study is
completely voluntary. You will not be paid for taking part in this study.
What are my rights as a research participant?
Participation in this study is completely voluntary. You do not have to answer any question you
do not want to or feel uncomfortable answering. If at any time and for any reason, if you no
longer prefer to participate in this study, please do not hesitate to inform the researcher. You can
always ask to take a short break during your interview session, stop and continue at a later date,
or withdraw from the study completely.
Withdrawal from this study at any time or for any reason will not need an explanation and you
will not be penalized in any way for your decision. If you decide to withdraw from this study
before it is completed, any information collected from you will be disposed of with the utmost
care and will not be used to determine the results of the study at its completion.
Who can I contact if I have questions or concerns about this research study?
If you have questions, you may contact the researcher at:
(a) Baz Allergy, Asthma & Sinus Center (Visalia)
Phone: (559) 713-1600
Hours: 9am-6pm (Monday-Friday)
Closed between the hours of 1-2pm (Monday-Friday)
(b) Baz Allergy, Asthma & Sinus Center (Hanford)
Phone: (559) 582-8500
Hours: 9am-6pm (Monday-Friday)
Closed between the hours of 1-2pm (Monday-Friday)
Consent
I have read the contents of this consent form and the research study has been explained to me. I
have been given the opportunity to ask questions and all my questions have been answered to my
satisfaction. If I have any additional questions, I have been told whom to contact. I agree to
participate in the research study described above and will receive a copy of this consent form.

______________________________________________________
Participant’s Name (printed)

______________________________________________________
Participant’s Signature
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________________
Date

Appendix B: Consent Form (Spanish)
CALIFORNIA STATE UNIVERSITY, NORTHERN CALIFORNIA CONSORTIUM
DOCTOR OF NURSING PRACTICE
FORMULARIO DE CONSENTIMIENTO DE PARTICIPACIÓN EN INVESTIGACIÓN
Título de Estudio: ¿Existe una relación entre el comportamiento de adherencia a medicamentos
entre personas con dominio limitado del inglés (LEP, sus siglas en inglés), y los resultados
adversos del asma en adultos Hispanos con asma persistente moderada o severa?
Estudiante Realizando la Investigación: Archana Chandra, Enfermera Practicante Médica
¿Por qué está realizando este estudio?
Se le está pidiendo participar en este trabajo de investigación sobre adultos Hispanos asma
persistente moderada o severa. La meta de este estudio es descubrir si los pacientes Hispanos
quienes hablan bien el inglés tienen mejor control de su asma que aquellos pacientes Hispanos
quienes tienen dificultades para hablar inglés.
¿Qué haré yo si decido participar en este estudio?
1. Se le pedirá llenar un cuestionario sobre:
• Dominio de Inglés- le informará al investigador qué tan bien habla usted inglés.
• Adherencia a Medicamentos - le informará al investigador de la frecuencia con que usted usa
sus medicamentos controladores de asma.
• Control de Asma - le informará al investigador qué tan controlada esta su asma tomando los
medicamentos actuales.
• Calidad de vida- le informará al investigador qué tan satisfecho esta usted con lo bien que está
controlada su asma y con los medicamentos que está tomando.
• Educación de Salud- le informará al investigador qué tan bien entiende usted la información
médica.
2. Se le pedirá realizar una prueba funcional de espirometría. Esta es la misma prueba que usted
hace en cada cita de seguimiento para descubrir su capacidad de funcionamiento pulmonar.
3. Se le pedirá que proporcione su información personal tal como edad, género, sexo, promedio
de ingreso anual y nivel de preparación escolar.
4. Se le pedirá proporcionar información sobre su historial del asma tal como cuántos años ha
sufrido de asma, qué tan seguido tiene usted crisis de asma, qué tan seguido ha ido a la
emergencia, y si lo han entubado por una crisis grave de asma.
Tiempo del Estudio: La participación en el estudio tomará aproximadamente 30 a 45 minutos
por visita. Después de la visita inicial, a cada participante se le pedirá que dé seguimiento con su
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clínica asignada (Visalia o Hanford) en 3 meses. Esto no incluye visitas por enfermedades que el
participante tenga que programar entre la visita de 3 meses requerida.
Localidad del Estudio: Todo trámite de estudio se llevará acabo en las clínicas Baz Allergy en
Visalia y Hanford. Si usted es paciente en el consultorio de Visalia, usted seguirá acudiendo a
citas en Visalia y vice versa. No se le pedirá que viaje a otra localidad en ningún momento
durante el estudio.
¿Cuáles son los posibles riesgos o molestias?
Según lo mejor de mi conocimiento su participación en este estudio no le ocasionará ningún
riesgo físico o emocional a usted mayor a lo que le cause su vida cotidiana. Si usted siente
cualquier molestia emocional o psicológica en cualquier momento durante la entrevista, usted se
puede tomar un descanso o pedir que se pare la entrevista. Si se siente incómodo con alguna
pregusta, también puede optar por no contestarla o pasar a la siguiente pregunta.
¿Cuáles son los posibles beneficios para mi y los demás?
El participar en esta investigación quizá no le beneficie a usted en lo personal. Este estudio está
diseñado para aprender más a cerca de los adultos Hispanos con asma que tienen dificultad para
hablar el inglés. Los resultados de este estudio se usarán para ayudar a pacientes en situaciones
similares a mejorar la calidad de su cuidado del asma en el futuro.
Como con toda investigación, existe la posibilidad de que pueda ocurrir una transgresión a la
confidencialidad de la información que obtengamos de usted– tomaremos todas las medidas para
minimizar este riesgo. Esto se aborda en más detalle en la parte inferior de este formulario.
¿Cómo se protegerá la información que obtenga de mi, y cómo se compartirá esta
información?
Los resultados de este estudio se pueden usar en presentaciones o publicaciones en el futuro.
Toda información obtenida de usted se manejará con la más estricta confidencialidad. Si los
resultados de este estudio son presentados o publicados, los nombres individuales, información
de contacto y cualquier otra información que se pudiera usar para identificarlo a usted
personalmente nunca se utilizará.
Para amenorar riesgos a la confidencialidad, a cada participante se le asignará un número y este
número estará enlazado a su información. Los nombres de los participantes u otra información
personal no se usarán para representar a los participantes individuales. Toda la información se
almacenará en un gabinete bajo candado en la residencia del investigador. Una vez que concluya
la investigación todos los datos colectados serán destruidos y deshechos con el mayor de los
cuidados.
Puede que compartamos datos que obtuvimos de usted para uso en estudios de investigación en
el futuro o con otros investigadores – si llegáramos a compartir datos sobre usted, removeremos
cualquier información que lo identifique antes de compartirlo.
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Si creemos que usted tiene intención de lastimares a si mismo o a otros, notificaremos a las
personas adecuadas con esta información.
Información Financiera
La participación en este estudio no significará ningún costo adicional para usted. Participar en
este estudio es completamente voluntario. No se le pagará por participar en el estudio.
¿Cuáles son mis derechos como participante del estudio?
Participar en este estudio es completamente voluntario. Usted no tiene obligación de contestar
cualquier pregunta que no quiera o que se sienta incomodo contestando. Si en cualquier
momento y por cualquier motivo, prefiere ya no seguir participando en el estudio, por favor no
vacile en informárselo al investigador. Siempre podrá tomarse un pequeño descanso durante la
entrevista, parar la sesión para seguir en otra fecha o darse de baja completamente del estudio.
Si se da de baja del estudio en cualquier momento, por cualquier motivo no es necesario que dé
una explicación y no será penalizado de ninguna forma por su decisión. Si usted decide retirase
del estudio antes de que se complete, todos los datos colectados serán deshechos con el mayor
cuidado y no se usarán para determinar los resultados del estudio cuando este concluya.
¿Con quién me comunico si tengo preguntas o inquietudes sobre este estudio?
Si tiene preguntas, puede contactarse con el investigador en:
(a) Baz Allergy, Asthma & Sinus

Center (Visalia)

Tel: (559) 713-1600
Horario: 9am-6pm (Lunes-Viernes)
Cierran entre 1-2pm (Lunes-Viernes)
(b) Baz Allergy, Asthma & Sinus Center (Hanford)
Tel: (559) 582-8500
Horario: 9am-6pm (Lunes-Viernes)
Cierran entre 1-2pm (Lunes-Viernes)
Consentimiento
He leído el contenido de este formulario de consentimiento y se me ha explicado el estudio. Se
me ha dado la oportunidad de hacer preguntas y todas se han contestado a mi satisfacción. Si
tengo más preguntas, me han dicho con quien contactarme. Estoy de acuerdo en participar en
este estudio de investigación como se describe anteriormente y se me entregará una copia de este
consentimiento.
______________________________________________________
Nombre del Participante (en letra de molde)
______________________________________________________
Firma del Participante
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Fecha

Appendix C: Short Test of Functional Health Literacy (S-TOFHLA)
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Appendix D: Short Test of Functional Health Literacy (S-TOFHLA) (Spanish)
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Appendix E: Asthma Control Questionnaire (ACQ)
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Appendix F: Asthma Control Questionnaire (ACQ) (Spanish)
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Appendix G: Asthma Quality of Life Questionnaire
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Appendix H: Asthma Quality of Life Questionnaire (Spanish)
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Appendix I: Medication Adherence Rating Scale (MARS)
Medication Adherence Rating Scale (MARS)
This scale is based on two already existing self-report measures of compliance. The
first is the Drug Attitude Inventory (DAI) (Hogan, Awad and Eastwood, 1983), and the
second is the Medication Adherence Questionnaire (MAQ) (Morisky, Green and Levine,
1986). These compliance measures have been combined to produce a compliance
scale.
The MARS consists of 10 items that require yes/no responses. The first 4 items are
based on the MAQ, and are scored, no = 1 and yes = 0. The remaining items are from
the DAI and are coded as follows: Q5, Q6, Q9, Q10, no = 1 and yes = 0; Q7, Q8, no = 0
and yes = 1. A total score will then reflect a greater degree of compliance if it is high,
and non-compliance if it is low. However one must always keep in mind that any
measure of self-reported compliance will overestimate compliance by approximately
30%.
Hogan, T P, Awad, A G, and Eastwood, R (1983) A self-report scale predictive of drug
compliance in schizophrenics: reliability and discriminative validity, Psychological
Medicine, 13, 177-183.
Morisky, D E, Green, L W, and Levine, D M (1986) Concurrent and predictive validity of
a self-reported measure of medication adherence. Medical Care, 24(1), 67-74.
____________________________________________________________
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Medication Adherence Rating Scale
Please respond to the following statements by circling the response which best
describes your behaviour or the attitude you have held toward your medication in the
past week.
1. Do you ever forget to take your medication?

Yes / No

2. Are you careless at times about taking your medicine?

Yes / No

3. When you feel better,
do you sometimes stop taking your medicine?

Yes / No

4. Sometimes if you feel worse when you take the medicine,
do you stop taking it?

Yes / No

5. I take my medication only when I am sick

Yes / No

6. It is unnatural for my mind and body
to be controlled by medication

Yes / No

7. My thoughts are clearer on medication

Yes / No

8. By staying on medication I can prevent getting sick

Yes / No

9. I feel weird, like a “zombie”, on medication

Yes / No

10. Medication makes me feel tired and sluggish

Yes / No
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Appendix J: Medication Adherence Rating Scale (MARS) (Spanish)
Escala de Evaluación de Adherencia a Medicamentos (MARS)
Esta escala se basa en dos medidas del cumplimento de autoinforme ya existentes. La
primera es el Inventario de Actitud a Medicamentos (DAI) (Hogan, Awad y Eastwood,
1983), y la segunda es el Cuestionario de Adherencia a Medicamentos (MAQ) (Morisky,
Green y Levine, 1986). Estas medidas del cumplimiento se han combinado para
producir la escala de cumplimiento.
El MARS consiste de 10 preguntas/declaraciones que requieren respuestas de sí/no.
Las primeras 4 se basan en el MAQ, y se califican así: no = 1 y sí = 0. Las restantes
son del DAI y se codifican de la siguiente forma: Q5, Q6, Q9, Q10, no = 1 y sí = 0; Q7,
Q8, no = 0 y sí = 1. La suma total entonces reflejará un mayor grado de cumplimiento
si el resultado es alto y de no cumplimiento si es bajo. Sin embargo, uno debe
considerar que cualquier medida del cumplimiento auto informado sobreestimará el
cumplimiento por aproximadamente 30%.
Hogan, T P, Awad, A G, y Eastwood, R (1983) Escala de autoinforme predecible de
cumplimiento de medicamentos en esquizofrenia: fiabilidad y validez discriminatoria,
Medicina Psicológica, 13, 177-183.
Morisky, D E, Green, L W, y Levine, D M (1986) Validez concurrente y predecible de
medidas de autoinforme de adherencia a medicamento. Cuidado Médico, 24(1), 67-74.
Dr Katherine Thompson
Senior Research Fellow,
HYPE Clinic
35 Poplar Road Parkville VIC 3052
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Escala de Evaluación de Adherencia a Medicamentos
Por favor conteste a las siguientes declaraciones haciendo un círculo alrededor de la
respuesta que mejor describa su comportamiento o actitud hacia su medicamento en la
semana pasada.
1. ¿Se le ha olvidado a veces tomar su medicamento?

Sí / No

2. ¿Es a veces descuidado(a) para tomar su medicina?

Sí / No

3. ¿Cuando se siente mejor, a veces deja de tomar su
medicina?

Sí / No

4. ¿A veces, si se siente peor cuando se toma la medicina,
deja de tomarla?

Sí / No

5. Yo me tomo el medicamento sólo cuando estoy enfermo(a).

Sí / No

6. Es antinatural para mi mente y mi cuerpo estar controlado
por medicamento.

Sí / No

7. Mis pensamientos están más claros cuando tomo la medicina.

Sí / No

8. Al seguir tomando los medicamentos puedo prevenir
enfermarme.

Sí / No

9. Me siento raro(a), como “zombi”, tomando la medicina.

Sí / No

10. El medicamento me hace sentir cansado(a) y
perezoso(a)

Sí / No
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